"10.1371_journal.pone.0124283","plos one","2015-04-28T00:00:00Z","Albin Rudisch; Matthew Richard Dewhurst; Luminita Gabriela Horga; Nina Kramer; Nathalie Harrer; Meng Dong; Heiko van der Kuip; Andreas Wernitznig; Andreas Bernthaler; Helmut Dolznig; Wolfgang Sommergruber","Department of Lead Discovery, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; Department of Microbiology, Immunobiology and Genetics, Center of Molecular Biology, Max F. Perutz Laboratories, University of Vienna, Vienna, Austria; Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Baden-Württemberg, Germany","Conceived and designed the experiments: AR MRD LGH HVDK HD NK NH WS. Performed the experiments: AR MRD LGH NH. Analyzed the data: AR MRD LGH AW AB HD NK NH WS. Contributed reagents/materials/analysis tools: MD HVDK AW AB WS. Wrote the paper: AR WS AB HVDK HD.","AR, NH, AW and WS are employees of Boehringer Ingelheim RCV GmbH & Co KG. MRD, LGH and AB were employed at Boehringer Ingelheim RCV GmbH & Co KG during the whole course of this study. ABs present affiliation is Bayer HealthCare Pharmaceuticals. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2015","04","Albin Rudisch","AR",11,TRUE,8,4,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
